Member Info for FlyingHigher

15 left, as soon as someone buys 15 shares, the share price will go to £10.

Let's get the article out there "Apple uses Nanoco technology for imminent mass produced product", send the news to America and beyond, let the share price go up a bit, everyone can sell their shares and we can all move on from this tragic excuse for a company.

A great summary there TwoGood2Die.

In tech stocks, even a whiff of Apple confirmation could send the share price into orbit.

We see many ludicrous valuations on tech stocks across the board.

If Nanoco can board the right hype train, who knows where it could end up?

I wouldn't put my money on that though.

I do agree Daz, I don't think there's any credible case against this being Nano tech.

The rational concerns are around the scalability and longevity of the pro vision devices.

They're very gimmicky.

As a long-term Nanoco sufferer I've seen many such links made in the past, which have all led to nothing.

The Acer gaming monitor was certain to have been Nanoco tech according to the forums. Well perhaps it was because it got delayed and delayed and delayed then changed, then Nanoco tech wasn't used.

I speculated that Nanoco tech may have been the problem.

That can't be proven either way.

160,000-180,000 but sustained volumes unlikely.

Does anyone know how much Nanoco will get per device?

Probably something like £1 right?

Probably dull for a few years.

Historic disappointment and failure.

A capital return that could cause a huge crash on ex divi.

Great stuff

I'm not invested here anymore, but have been a long-term follower.

Production ready with unproven application and demand

Risks:

Capital return gives money to shareholders (hooray!) but then causes a decline on ex-divi.

STM ends their arrangement with Nanoco on completion of existing project.

Nano are left with no clear commercial prospects, but plenty of cash.

It then gets boring for a few years, so the share price remains depressed until another opportunity arises and probably fails again.

I didn't see the first update coming that transformed the Nanoco shareprice on litigation agreement and I then didn't see the disappointing announcement that followed. I was in and out of GGP many years ago when it was a penny and completely missed that one.

The point is here we don't know whether the return to shareholders will be that brilliant and it may even cause a temporary crash in the share price.

There's potential for some likely small uplift from STM but nothing particularly exciting for a while yet.

This is not an easy share to hype. It's operationally completely secure, but has very unclear opportunities that could either be OK or transformational. Previous such opportunities have led to disappointment.

Without the uncertainty of the capital return, the company is undervalued and would be better valued at 25p-30p with no consideration for IP, which is tricky to value.

There aren't that many shares in issue and the valuation is currently ludicrous. It will recover at some point and I hope that's in the near future. 20p on the recovery. 50p+ on the next update. I think this is perfectly realistic.

That's what I said back in 2014 and nothing but disappointment followed. Good luck all! (You may need it!)

A simple dividend of 12p would send the share price tumbling to 10p or less temporarily.

That would be the time to buy.

Still a no brainer by the way!

The 500k trade earlier looks like a sale, anybody have an idea?

What we don't know is how the capital return to shareholders will be done and this could collapse the share price on ex-divi.

The BIG elephant in the room is how the capital return to shareholders will be conducted.

This could cause a big crash on ex divi day, but then also cause a big surge beforehand.

I wouldn't invest before this is clear. If the entire amount is returned via dividend, the share price will crash below 10p on ex divi. That's the time to buy!

This is still all a bit vague and very much in the same tone as historic updates, which ultimately led to nothing.

Also the special dividend proposition is scary if it will come off the share price afterwards. If it turns out that way, buy in at pennies on ex dividend day.

I can't think they'd be stupid enough to do that.

I think a buy back is much more sensible.

When the company was in the pre-stages of 510k approval for the heart valve with no partnerships on the horizon, cash flow concerns and very much in the R&D phase, it was valued at £35.2m with 22m shares in issue = 160p per share.

Now the company has cash for 4 years, is on the brink of commercialisation through a potential partnership and is valued at a fraction of that.

The equivalent share price with the dilution is a little over 56p, but the company is in a healthier position, so that should be a minimum.